MedPath

Study of Probiotic supplements to reduce insulin resistance in gestational diabetes mellitus

Phase 3
Recruiting
Conditions
Side effects from probiotics&#45
diarrheaPrevention: Closed follow up ANC.
Probiotic supplements
infloran
GDM
gestational diabetes
HOMA&#45
IR
Registration Number
TCTR20170606002
Lead Sponsor
none
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
60
Inclusion Criteria

Singleton pregnancy
Age > 18 years old
No chronic disease
no probiotic supplements or probiotic foods used before study
no fetal anomaly
Patients agree to participate in the research

Exclusion Criteria

Use antibiotics during research
There are side effects of probiotic drug use
Other treatments(insulin)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HOMA-IR, fasting blood sugar, fasting insulin level weeks 0 and 4 after at least 12h of fasting blood samples
Secondary Outcome Measures
NameTimeMethod
Maternal weight gain, pregnancy outcome 4 weeks after intervention, at delivery scales
© Copyright 2025. All Rights Reserved by MedPath